New allelic arrangement CYP2D6*36x2 found in a Japanese poor metabolizer of debrisoquine

被引：19
|
作者：
Chida, M
Ariyoshi, N
Yokoi, T
Nemoto, N
Inaba, M
Kinoshita, M
Kamataki, T
机构：
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Div Pharmacobiodynam, Sapporo, Hokkaido, Japan
[2] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Toxicol, Toyama, Japan
[3] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan
[4] Otsuka Pharmaceut Co Ltd, Tokushima 77101, Japan
来源：
PHARMACOGENETICS | 2002年 / 12卷 / 08期
关键词：
CYP2D6*10; gene duplication; genotype;
D O I：
10.1097/00008571-200211000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：659 / 662
页数：4
相关论文
共 50 条
  • [1] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [2] A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype
    Chida, M
    Yokoi, T
    Nemoto, N
    Inaba, M
    Kinoshita, M
    Kamataki, T
    PHARMACOGENETICS, 1999, 9 (03): : 287 - 293
  • [3] Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
    Susce, Margaret T.
    Murray-Carmichael, Elaina
    de Leon, Jose
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (07): : 1356 - 1358
  • [4] Unique case of serotonin toxicity in a poor CYP2D6 metabolizer
    Feininger, E. Sterling
    Dulaney, Anna
    Sanders, Taylor
    Pikus, Angela
    Kopec, Kathryn
    CLINICAL TOXICOLOGY, 2023, 61 : 71 - 71
  • [5] Disposition of propafenone in a poor metabolizer of CYP2D6 with Gilbert's syndrome
    Dilger, K
    Meisel, P
    Hofmann, U
    Eichelbaum, M
    THERAPEUTIC DRUG MONITORING, 2000, 22 (03) : 366 - 368
  • [6] Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual
    Andrea Gaedigk
    Dorothee Frank
    Uwe Fuhr
    European Journal of Clinical Pharmacology, 2009, 65 : 97 - 100
  • [7] Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response
    Sowinski, KM
    Burlew, BS
    PHARMACOTHERAPY, 1997, 17 (06): : 1305 - 1310
  • [8] Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual
    Gaedigk, Andrea
    Frank, Dorothee
    Fuhr, Uwe
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (01) : 97 - 100
  • [9] Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment with bupropion
    Güzey, C
    Nordström, Å
    Spigset, O
    THERAPEUTIC DRUG MONITORING, 2002, 24 (03) : 436 - 437
  • [10] A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype
    Yokoi, T
    Kosaka, Y
    Chida, M
    Chiba, K
    Nakamura, H
    Ishizaki, T
    Kinoshita, M
    Sato, K
    Gonzalez, FJ
    Kamataki, T
    PHARMACOGENETICS, 1996, 6 (05): : 395 - 401
12345